AAAAAA

   
Results: 1-25 | 26-50 | 51-51
Results: 1-25/51
ENGINEERING FOR THE ENVIRONMENT - THE NEW MODEL ENGINEER AND HER ROLE
Authors: CLIFT R
Citation: R. Clift, ENGINEERING FOR THE ENVIRONMENT - THE NEW MODEL ENGINEER AND HER ROLE, Process safety and environmental protection, 76(B2), 1998, pp. 151-160
EXERGY ANALYSIS OF THE LIFE-CYCLE OF STEEL
Authors: MICHAELIS P JACKSON T CLIFT R
Citation: P. Michaelis et al., EXERGY ANALYSIS OF THE LIFE-CYCLE OF STEEL, Energy, 23(3), 1998, pp. 213-220
ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE
Authors: MORTON AJ GOOLEY T HANSEN JA APPELBAUM FR BRUEMMER B BJERKE JW CLIFT R MARTIN PJ PETERSDORF EW SANDERS JE STORB R SULLIVAN KM WOOLFREY A ANASETTI C
Citation: Aj. Morton et al., ASSOCIATION BETWEEN PRETRANSPLANT INTERFERON-ALPHA AND OUTCOME AFTER UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE, Blood, 92(2), 1998, pp. 394-401
EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR
Authors: DEMIRER T BUCKNER CD STORER B LILLEBY K ROWLEY S CLIFT R APPELBAUM FR STORB R BENSINGER WI
Citation: T. Demirer et al., EFFECT OF DIFFERENT CHEMOTHERAPY REGIMENS ON PERIPHERAL-BLOOD STEM-CELL COLLECTIONS IN PATIENTS WITH BREAST-CANCER RECEIVING GRANULOCYTE-COLONY-STIMULATING FACTOR, Journal of clinical oncology, 15(2), 1997, pp. 684-690
CLEAN TECHNOLOGY - THE IDEA AND THE PRACTICE
Authors: CLIFT R
Citation: R. Clift, CLEAN TECHNOLOGY - THE IDEA AND THE PRACTICE, Journal of chemical technology and biotechnology, 68(4), 1997, pp. 347-350
MARSHALL,V.C., 1990, THE SOCIAL ACCEPTABILITY OF THE CHEMICAL AND PROCESS INDUSTRIES - A PROPOSAL FOR AN INTEGRATED APPROACH, TRANS ICHEME,68 (PART B), 83-93 - COMMENTARY
Authors: CLIFT R
Citation: R. Clift, MARSHALL,V.C., 1990, THE SOCIAL ACCEPTABILITY OF THE CHEMICAL AND PROCESS INDUSTRIES - A PROPOSAL FOR AN INTEGRATED APPROACH, TRANS ICHEME,68 (PART B), 83-93 - COMMENTARY, Chemical engineering research & design, 75, 1997, pp. 6-6
PATCHY CLEANING OF RIGID GAS FILTERS .1. A PROBABILISTIC MODEL
Authors: DUO W KIRKBY NF SEVILLE JPK CLIFT R
Citation: W. Duo et al., PATCHY CLEANING OF RIGID GAS FILTERS .1. A PROBABILISTIC MODEL, Chemical Engineering Science, 52(1), 1997, pp. 141-151
USE OF INTERFERON-ALPHA-2A TO TREAT CYTOGENETIC RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER MARROW TRANSPLANTATION
Authors: HIGANO CS CHIELENS D RASKIND W BRYANT E FLOWERS MED RADICH J CLIFT R APPELBAUM F
Citation: Cs. Higano et al., USE OF INTERFERON-ALPHA-2A TO TREAT CYTOGENETIC RELAPSE OF CHRONIC MYELOID-LEUKEMIA AFTER MARROW TRANSPLANTATION, Blood, 90(7), 1997, pp. 2549-2554
IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE
Authors: MORTON AJ GOOLEY T HANSEN JA APPELBAUM FR BJERKE JW CLIFT R MARTIN PJ PETERSDORF EW SANDERS JE STORB R SULLIVAN KM ANASETTI C
Citation: Aj. Morton et al., IMPACT OF PRETRANSPLANT INTERFERON-ALPHA (IFN-ALPHA) ON OUTCOME OF UNRELATED DONOR MARROW TRANSPLANTS FOR CHRONIC MYELOID-LEUKEMIA (CML) INFIRST CHRONIC PHASE, Blood, 90(10), 1997, pp. 536-536
UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML)
Authors: ANASETTI C GOOLEY T CLIFT R PETERSDORF E MARTIN P HANSEN J
Citation: C. Anasetti et al., UNRELATED DONOR MARROW TRANSPLANTATION FOR CHRONIC MYELOID-LEUKEMIA (CML), Experimental hematology, 24(9), 1996, pp. 724-724
EFFECT OF MIXED CHIMERISM ON GRAFT-VERSUS-HOST DISEASE, DISEASE RECURRENCE AND SURVIVAL AFTER HLA-IDENTICAL MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA OR CHRONIC MYELOGENOUS LEUKEMIA
Authors: HUSS R DEEG HJ GOOLEY T BRYANT E LEISENRING W CLIFT R BUCKNER CD MARTIN P STORB R APPELBAUM FR
Citation: R. Huss et al., EFFECT OF MIXED CHIMERISM ON GRAFT-VERSUS-HOST DISEASE, DISEASE RECURRENCE AND SURVIVAL AFTER HLA-IDENTICAL MARROW TRANSPLANTATION FOR APLASTIC-ANEMIA OR CHRONIC MYELOGENOUS LEUKEMIA, Bone marrow transplantation, 18(4), 1996, pp. 767-776
HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER
Authors: DEMIRER T BUCKNER CD APPELBAUM FR CLIFT R STORB R MYERSON D LILLEBY K ROWLEY S BENSINGER WI
Citation: T. Demirer et al., HIGH-DOSE BUSULFAN AND CYCLOPHOSPHAMIDE FOLLOWED BY AUTOLOGOUS TRANSPLANTATION IN PATIENTS WITH ADVANCED BREAST-CANCER, Bone marrow transplantation, 17(5), 1996, pp. 769-774
BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR AUTOLOGOUS OR SYNGENEIC MARROW TRANSPLANTATION FOR ACUTE AND CHRONICMYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS
Authors: DEMIRER T BUCKNER CD APPELBAUM FR BENSINGER WI SANDERS J LAMBERT K CLIFT R FEFER A STORB R SLATTERY JT
Citation: T. Demirer et al., BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR AUTOLOGOUS OR SYNGENEIC MARROW TRANSPLANTATION FOR ACUTE AND CHRONICMYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS, Bone marrow transplantation, 17(4), 1996, pp. 491-495
BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR ALLOGENEIC MARROW TRANSPLANTATION IN ADVANCED ACUTE AND CHRONIC MYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS
Authors: DEMIRER T BUCKNER CD APPELBAUM FR LAMBERT K BENSINGER WI CLIFT R STORB R SLATTERY JT
Citation: T. Demirer et al., BUSULFAN, CYCLOPHOSPHAMIDE AND FRACTIONATED TOTAL-BODY IRRADIATION FOR ALLOGENEIC MARROW TRANSPLANTATION IN ADVANCED ACUTE AND CHRONIC MYELOGENOUS LEUKEMIA - PHASE-I DOSE-ESCALATION OF BUSULFAN BASED ON TARGETED PLASMA-LEVELS, Bone marrow transplantation, 17(3), 1996, pp. 341-346
POWDER TECHNOLOGY AND PARTICLE SCIENCE
Authors: CLIFT R
Citation: R. Clift, POWDER TECHNOLOGY AND PARTICLE SCIENCE, Powder technology, 88(3), 1996, pp. 335-339
DUST CAKE DETACHMENT FROM GAS FILTERS
Authors: KOCH D SEVILLE J CLIFT R
Citation: D. Koch et al., DUST CAKE DETACHMENT FROM GAS FILTERS, Powder technology, 86(1), 1996, pp. 21-29
ALLOGENEIC MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - AN ANALYSIS OF RISK-FACTORS ON OUTCOME
Authors: BENSINGER WI BUCKNER CD ANASETTI C CLIFT R STORB R BARNETT T CHAUNCEY T SHULMAN H APPELBAUM FR
Citation: Wi. Bensinger et al., ALLOGENEIC MARROW TRANSPLANTATION FOR MULTIPLE-MYELOMA - AN ANALYSIS OF RISK-FACTORS ON OUTCOME, Blood, 88(7), 1996, pp. 2787-2793
ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES - A RETROSPECTIVE COMPARISON WITH MARROW TRANSPLANTATION
Authors: BENSINGER WI CLIFT R MARTIN P APPELBAUM FR DEMIRER T GOOLEY T LILLEBY K ROWLEY S SANDERS J STORB R BUCKNER CD
Citation: Wi. Bensinger et al., ALLOGENEIC PERIPHERAL-BLOOD STEM-CELL TRANSPLANTATION IN PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES - A RETROSPECTIVE COMPARISON WITH MARROW TRANSPLANTATION, Blood, 88(7), 1996, pp. 2794-2800
TRANSPLANTATION OF ALLOGENEIC CD34(-BLOOD STEM-CELLS IN PATIENTS WITHADVANCED HEMATOLOGIC MALIGNANCY() PERIPHERAL)
Authors: BENSINGER WI BUCKNER CD SHANNONDORCY K ROWLEY S APPELBAUM FR BENYUNES M CLIFT R MARTIN P DEMIRER T STORB R LEE M SCHILLER G
Citation: Wi. Bensinger et al., TRANSPLANTATION OF ALLOGENEIC CD34(-BLOOD STEM-CELLS IN PATIENTS WITHADVANCED HEMATOLOGIC MALIGNANCY() PERIPHERAL), Blood, 88(11), 1996, pp. 4132-4138
REDUCTION IN GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER TRANSPLANTATION OF CD34 SELECTED, ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN OLDER PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES
Authors: BENSINGER WI ROWLEY S LILLEBY K CLIFT R BUCKNER CD KUNKEL L MILLS B CHAUNCEY T STORB R APPELBAUM FR
Citation: Wi. Bensinger et al., REDUCTION IN GRAFT-VERSUS-HOST-DISEASE (GVHD) AFTER TRANSPLANTATION OF CD34 SELECTED, ALLOGENEIC PERIPHERAL-BLOOD STEM-CELLS (PBSC) IN OLDER PATIENTS WITH ADVANCED HEMATOLOGIC MALIGNANCIES, Blood, 88(10), 1996, pp. 1672-1672
FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS
Authors: BENSINGER W APPELBAUM F ROWLEY S STORB R SANDERS J LILLEBY K GOOLEY T DEMIRER T SCHIFFMAN K WEAVER C CLIFT R CHAUNCEY T KLARNET J MONTGOMERY P PETERSDORF S WEIDEN P WITHERSPOON R BUCKNER CD
Citation: W. Bensinger et al., FACTORS THAT INFLUENCE COLLECTION AND ENGRAFTMENT OF AUTOLOGOUS PERIPHERAL-BLOOD STEM-CELLS, Journal of clinical oncology, 13(10), 1995, pp. 2547-2555
GREENPEACE LIFE-CYCLE APPEAL
Authors: CLIFT R
Citation: R. Clift, GREENPEACE LIFE-CYCLE APPEAL, Chemical engineer, (600), 1995, pp. 3-3
CLEAN TECHNOLOGY - AN INTRODUCTION
Authors: CLIFT R
Citation: R. Clift, CLEAN TECHNOLOGY - AN INTRODUCTION, Journal of chemical technology and biotechnology, 62(4), 1995, pp. 321-326
LIFE-CYCLE ASSESSMENT AND LINEAR-PROGRAMMING - ENVIRONMENTAL OPTIMIZATION OF PRODUCT SYSTEM
Authors: AZAPAGIC A CLIFT R
Citation: A. Azapagic et R. Clift, LIFE-CYCLE ASSESSMENT AND LINEAR-PROGRAMMING - ENVIRONMENTAL OPTIMIZATION OF PRODUCT SYSTEM, Computers & chemical engineering, 19, 1995, pp. 229-234
BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA
Authors: APPELBAUM FR CLIFT R RADICH J ANASETTI C BUCKNER CD
Citation: Fr. Appelbaum et al., BONE-MARROW TRANSPLANTATION FOR CHRONIC MYELOGENOUS LEUKEMIA, Seminars in oncology, 22(4), 1995, pp. 405-411
Risultati: 1-25 | 26-50 | 51-51